Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools
Sign Up to like & getrecommendations! Published in 2020 at "Biotechnology Letters"
DOI: 10.1007/s10529-020-02792-6
Abstract: Viral oncoproteins are ideal targets in therapeutic vaccines for functional inhibition of human papillomaviruses (HPVs). Herein, we designed the peptide constructs derived from E5 and E7 oncoproteins of high-risk HPV types 16, 18, 31 and… read more here.
Keywords: high risk; risk hpv; hpv16; development hpv16 ... See more keywords